Article Figures & Data
Tables
Primary specialty of PBRN Mixed 53 (40.5) Family medicine 42 (32.1) Pediatrics 16 (12.2) General internal medicine 8 (6.1) Nursing 4 (3.1) Other 8 (6.1) Presence of members by clinical discipline Physicians 122 (93.1) Nurse practitioners 93 (71.0) Physician assistants 76 (58.0) Other clinician types 67 (51.2) Members with an EHR (%) 51–100 64 (48.9) 26–50 35 (26.7) 1–25 22 (16.8) None or unknown 10 (7.6) Geographic coverage Regional 40 (30.5) State 36 (27.5) Local or citywide 30 (22.9) National 25 (19.1) Primary affiliation University 85 (64.9) Not-for-profit 38 (29.0) Professional organization 5 (3.8) For-profit 1 (0.8) None 0 (0) Other 2 (1.5) Funding sources (during past 5 years)* US government 83 (63.4) Academia 63 (48.1) Nonprofit 51 (38.9) State/local government 32 (24.4) Professional organization 31 (23.7) For-profit/commercial 23 (17.6) Government outside United States 1 (0.8) Other sources 14 (10.7) Target populations* Underserved 79 (60.3) Low income 71 (54.2) Minority 71 (54.2) Inner city 51 (38.9) Rural 49 (37.4) No target population 42 (32.1) Other (unspecified) 16 (12.2) Relationship to CTSA None 53 (40.5) Funded with CTSA 66 (50.4) Planning with CTSA 12 (9.2) Multinetwork project/study (during past year) None 36 (27.5) None yet, but planning 38 (29.0) No, but have in the past 10 (7.6) Yes 47 (35.9) Data provided as n (%).
↵* Multiple responses permitted.
EHR, electronic health record; CTSA, Clinical Translational Science Award.
Studies ever conducted, n 1–3 29 (24.0) 4–7 24 (19.8) 8–16 25 (20.7) 17–39 21 (17.4) ≥40 22 (18.2) Used EHR for research 83 (68.6) AHRQ priority health conditions studied (during past 5 years)* Diabetes mellitus 60 (49.6) Obesity 51 (42.1) Pulmonary disease/asthma 44 (36.4) Cardiovascular disease 42 (34.7) Mental health disorders 34 (28.1) Cancer 32 (26.4) Substance abuse 18 (14.9) Development delays 14 (11.6) Infectious disease (including HIV/AIDs, sexually transmitted diseases) 13 (10.7) Dementia 11 (9.1) Arthritis and joint disease 10 (8.3) Pregnancy and childbirth 10 (8.3) Study designs used (during past 5 years)* Observational epidemiology 66 (54.5) Health systems/outcome research 63 (52.1) Best practice research/modeling 61 (50.4) Implementation research 39 (32.2) Clinical trials 34 (28.1) Comparative effectiveness research 31 (25.6) Methodological research 22 (18.2) Nonpractice-based community health intervention 18 (14.9) Pharmaceutical clinical trials 12 (9.9) Data provided as n (%). Ten developing PBRNs that had not completed a research project were excluded from the description of PBRN research.
↵* Multiple responses permitted.
EHR, electronic health record; AHRQ, Agency for Health care Research and Quality.
- Table 3. Most Commonly Reported Practice-based Research Network (PBRN) Strengths and Challenges*
Strengths Leadership 86 (65.6) Study development 79 (60.3) Study management 76 (58.0) Data management 71 (54.2) Network staff 70 (53.4) Diversity of patient population 68 (51.9) Capacity to conduct research 60 (45.8) Geographic distribution 59 (45.0) Access to patient data 58 (44.3) IRB/HIPAA 58 (44.3) Recruitment 54 (41.2) Computer access at practices 53 (40.5) Research agenda setting 52 (39.7) Challenges Infrastructure funding 89 (67.9) Infrastructure support 69 (52.7) Compensation strategies 64 (48.9) EMR availability/interface 57 (43.5) Community participation 55 (42.0) Provider training 52 (39.7) Member involvement 52 (39.7) Data provided as n (%).
↵* Reported by ≥40% of the practice-based research networks (N = 131).
IRB, institutional review board; HIPAA, Health Insurance Privacy and Accountability Act; EMR, electronic medical record.